Pages that link to "Q71870087"
Jump to navigation
Jump to search
The following pages link to Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure (Q71870087):
Displaying 50 items.
- Angiotensin receptor blockers for heart failure (Q24199125) (← links)
- Angiotensin receptor blockers in heart failure after the ELITE II trial (Q24792591) (← links)
- Angiotensin AT(1) receptor signalling modulates reparative angiogenesis induced by limb ischaemia (Q28344851) (← links)
- Thirty Years of Evidence on the Efficacy of Drug Treatments for Chronic Heart Failure With Reduced Ejection Fraction: A Network Meta-Analysis (Q30239022) (← links)
- Meta-analysis of observed mortality data from all-controlled, double-blind, multiple-dose studies of losartan in heart failure. Losartan Heart Failure Mortality Meta-analysis Study Group (Q30608935) (← links)
- Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II. (Q31383623) (← links)
- Effects of the replacement of the angiotensin converting enzyme inhibitor enalapril by the angiotensin II receptor blocker telmisartan in patients with congestive heart failure. The replacement of angiotensin converting enzyme inhibition (REPLACE) i (Q31966048) (← links)
- Recent insight into therapy of congestive heart failure: focus on ACE inhibition and angiotensin-II antagonism (Q33588571) (← links)
- Current and novel pharmacologic approaches in advanced heart failure (Q33688965) (← links)
- Comparative safety and tolerability of angiotensin II receptor antagonists (Q33703340) (← links)
- Angiotensin II receptor antagonists (Q33851581) (← links)
- Losartan: a review of its use, with special focus on elderly patients (Q33914247) (← links)
- Management of heart failure: evidence versus practice. Does current prescribing provide optimal treatment for heart failure patients? (Q34070051) (← links)
- Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan (Q34150300) (← links)
- Formulating clinical strategies for angiotensin antagonism: a review of preclinical and clinical studies (Q34237411) (← links)
- Medical management of mild-to-moderate heart failure before the advent of beta blockers (Q34239882) (← links)
- Improving clinical decisions and outcomes with information: a review (Q34243181) (← links)
- Treatment of heart failure in patients with diabetes mellitus (Q34510983) (← links)
- Angiotensin II receptor antagonists in chronic heart failure: where do they fit? (Q34716915) (← links)
- Regulation of peripheral vascular tone in patients with heart failure: contribution of angiotensin II (Q35368799) (← links)
- Does the addition of losartan improve the beneficial effects of ACE inhibitors in patients with anterior myocardial infarction? A pilot study (Q35372556) (← links)
- Drug therapy in chronic heart failure (Q35518236) (← links)
- Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: what we know and current controversies (Q35626136) (← links)
- The role of type 1 angiotensin receptors on T lymphocytes in cardiovascular and renal diseases (Q36532932) (← links)
- Inhibitors of the renin-angiotensin system in established cardiac failure (Q36835377) (← links)
- Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors (Q37365932) (← links)
- Peripartum cardiomyopathy: summary of an international survey on peripartum cardiomyopathy (Q40800730) (← links)
- QUANTIFICATION OF EXERCISE TOLERANCE IN CONGESTIVE HEART FAILURE AND ROLE OF ACE INHIBITORS. (Q41154396) (← links)
- Novel drugs and current therapeutic approaches in the treatment of heart failure (Q41177950) (← links)
- Drug selection for optimal treatment of hypertension in the elderly (Q41544197) (← links)
- Angiotensin II type-I receptor antagonists in the treatment of heart failure (Q41701250) (← links)
- Peripartum cardiomyopathy: a comprehensive review (Q41720175) (← links)
- Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular events in patients with heart failure: a meta-analysis of randomized controlled trials (Q42276363) (← links)
- Losartan reduces mortality in a genetic model of heart failure. (Q42941858) (← links)
- Update on Renin-Angiotensin-aldosterone blockade in heart failure (Q43237411) (← links)
- First dose hypotension after angiotensin converting enzyme inhibitor captopril and angiotensin II blocker losartan in patients with acute myocardial infarction (Q43509818) (← links)
- Evidence based medical treatment of heart failure (Q43645092) (← links)
- Ramipril improves hemodynamic recovery but not microvascular response to ischemia in spontaneously hypertensive rats. (Q44001353) (← links)
- Safety and efficacy of valsartan versus enalapril in heart failure patients (Q44123601) (← links)
- Prospective evaluation comparing the effects of enalapril and losartan in left ventricular remodeling after acute myocardial infarction (Q44471781) (← links)
- Sarcoidosis in a pregnant woman. (Q51549323) (← links)
- Rationale, background, and design of the randomized angiotensin receptor antagonist--angiotensin-converting enzyme inhibitor study (RAAS) (Q71771578) (← links)
- ARCTIC: assessment of haemodynamic response in patients with congestive heart failure to telmisartan: a multicentre dose-ranging study in Canada (Q73128324) (← links)
- Effects of angiotensin II receptor blockade on N-terminal proatrial natriuretic factor plasma levels in chronic heart failure (Q73504162) (← links)
- Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure (Q73547027) (← links)
- Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors (Q73599567) (← links)
- A comparison of intervention with losartan or captopril in acute myocardial infarction (Q73609011) (← links)
- Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure. The Losartan Pilot Exercise Study Investigators (Q73746095) (← links)
- Haemodynamic, neurohumoral and exercise effects of losartan vs. captopril in chronic heart failure: results of an ELITE trial substudy. Evaluation of Losartan in the Elderly (Q74152297) (← links)
- [Therapy of chronic cardiac insufficiency with ACE inhibitors versus AT1 receptor antagonists. Is there a difference?] (Q74245995) (← links)